2018 American Transplant Congress
The Secret is Selection of Muscular Dystrophy for Success after Heart Transplant
Cedars Sinai Medical Center, Los Angeles.
Purpose: Patients with muscular dystrophy may have an associated cardiomyopathy, resulting in advanced heart failure requiring transplantation. However, the skeletal muscle dysfunction can result in…2018 American Transplant Congress
Comparing Outcomes between Induction Immunosuppressive Therapies in Simultaneous Heart/Kidney Transplantation
Virginia Commonwealth University, Richmond.
Introduction: There is no published data on the risks and benefits of Induction immunosuppression in simultaneous heart/kidney transplant (SHKT) patients.Methods: We analyzed all SHKT performed…2018 American Transplant Congress
Impact of Pre-Transplant Non-Dialysis Renal Dysfunction in Heart Transplant Recipients on Post-Transplant ESRD: A UNOS Database Analysis
Medicine, Loyola University Medical Center, Maywood, IL.
Dialysis prior to heart transplant (HTx) is a strong predictor of patient death and is a common indication for simultaneous heart/kidney transplantation (SHK). The association…2018 American Transplant Congress
Combined Heart–Kidney Compared to Isolated Heart Transplant in Patients with Chronic Kidney Disease – A Single Center Experience
Tufts University School of Medicine, Boston, MA.
Background: Severe irreversible renal dysfunction has been a contraindication for heart transplant (HTx); however, combined heart-kidney transplant (HKTx) is an accepted therapeutic option for concomitant…2017 American Transplant Congress
Impact of mTOR-Inhibition on Tolerance-Induction Following Heart Transplantation.
Clinic for Cardiac Surgery, Heart Center Leipzig, Leipzig, Germany
Introduction: The mammalian target of rapamycin (mTOR) is a central regulator of the immune system and therefore one target of immunosuppressive drug therapy. Tolerance-inducing properties…2017 American Transplant Congress
Antibody Mediated Rejection and Donor Specific Antibodies in Heart Transplant Patients: Single Center Experience.
BACKGROUND AND AIMS: Preexisting donor specific antibodies (DSA) cause acute antibody mediated rejection (AMR), which can be avoided during pre-transplant work up. Diagnosis and management…2017 American Transplant Congress
Is the Current Heart Allocation System Just and Fair for Blood Type O Recipients? – A Propensity-Matched Analysis of 34353 Patients in the UNOS Registry.
Columbia University Medical Center, New York, NY
Purpose: There is a known disparity between the waiting time on heart transplant (HTx) between blood type O and non-O recipients. This difference is mainly…2017 American Transplant Congress
Risk of Amiodarone and Permanent Pacemaker Placement After Heart Transplantation.
Cedars-Sinai Heart Institute, Los Angeles
Background: Patients (pts) with end stage heart disease undergoing heart transplantation (HT) may be on amiodarone (AD) for arrhythmias. AD may persist for weeks after…2017 American Transplant Congress
Young African American Heart Transplant Recipients Have an Elevated Risk of Post-Transplant Mortality.
African American (AA) race is associated with worse survival among heart transplant recipients. Even after controlling for socioeconomic and clinical characteristics, racial disparities persist and…2017 American Transplant Congress
Post-Transplant Sensitization: Does it Make a Difference in the Development of First-Year Intimal Thickening?
Cedars-Sinai Heart Institute, Los Angeles
Background: The development of donor specific antibody (DSA) after heart transplantation has been reported to be associated with the development of cardiac allograft vasculopathy (CAV).…
- « Previous Page
- 1
- …
- 18
- 19
- 20
- 21
- 22
- …
- 30
- Next Page »